Boceprevir-induced Herpes Zoster
Herpes zoster is caused by reactivation of the varicella zoster virus (VZV), that attacks peripheral or cranial nerves and result in painful cutaneous inflammation. Boceprevir is a protease inhibitor which used as a new therapeutic agent for chronic hepatitis C infection. Boceprevir associated herpes zoster is extremely rare condition. We present herpes zoster infection assosiated Boceprevir in patint with chronic hepatitis C. How to cite this article: Babali A, Cakal B, Tanoglu A, Karaahmet F, Kekilli M. Boceprevir-induced Herpes Zoster. Euroasian J Hepatogastroenterol, 2018;8(2):161-162.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Euroasian journal of hepato-gastroenterology - 8(2018), 2 vom: 20. Juli, Seite 161-162 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Babalı, Ayşegul [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 01.10.2020 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.5005/jp-journals-10018-1282 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM294528288 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM294528288 | ||
| 003 | DE-627 | ||
| 005 | 20231225081659.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5005/jp-journals-10018-1282 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0981.xml |
| 035 | |a (DE-627)NLM294528288 | ||
| 035 | |a (NLM)30828558 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Babalı, Ayşegul |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Boceprevir-induced Herpes Zoster |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 01.10.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Herpes zoster is caused by reactivation of the varicella zoster virus (VZV), that attacks peripheral or cranial nerves and result in painful cutaneous inflammation. Boceprevir is a protease inhibitor which used as a new therapeutic agent for chronic hepatitis C infection. Boceprevir associated herpes zoster is extremely rare condition. We present herpes zoster infection assosiated Boceprevir in patint with chronic hepatitis C. How to cite this article: Babali A, Cakal B, Tanoglu A, Karaahmet F, Kekilli M. Boceprevir-induced Herpes Zoster. Euroasian J Hepatogastroenterol, 2018;8(2):161-162 | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Boceprevir | |
| 650 | 4 | |a Herpes zoster | |
| 650 | 4 | |a Infection. | |
| 700 | 1 | |a Cakal, Basak |e verfasserin |4 aut | |
| 700 | 1 | |a Tanoglu, Alpaslan |e verfasserin |4 aut | |
| 700 | 1 | |a Karaahmet, Fatih |e verfasserin |4 aut | |
| 700 | 1 | |a Kekilli, Murat |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Euroasian journal of hepato-gastroenterology |d 2014 |g 8(2018), 2 vom: 20. Juli, Seite 161-162 |w (DE-627)NLM278670431 |x 2231-5047 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2018 |g number:2 |g day:20 |g month:07 |g pages:161-162 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5005/jp-journals-10018-1282 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2018 |e 2 |b 20 |c 07 |h 161-162 | ||